This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Life Technologies Corporation. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Innovations of Elizabeth Linch in Immune Repertoire Sequencing
Introduction
Elizabeth Linch is an accomplished inventor based in Menifee, CA (US). She has made significant contributions to the field of immune repertoire sequencing, holding 2 patents that enhance the understanding of immune responses. Her work focuses on developing methods and compositions that improve the accuracy and resolution of sequencing immune cell receptors.
Latest Patents
One of her latest patents is titled "Compositions and methods for immune repertoire sequencing." This patent provides methods, compositions, kits, and systems that are useful in determining and evaluating the immune repertoire using genomic DNA from biological samples. The invention includes target-specific primer panels that allow for effective amplification of sequences of T cell receptor and/or B cell receptor chains. This advancement leads to improved sequencing accuracy and resolution over the repertoire. Additionally, the nucleic acid sequences of variable regions associated with immune cell receptors are determined to effectively portray clonal diversity and differences in the immune cell repertoire of biological samples.
Career Highlights
Elizabeth Linch is currently associated with Life Technologies Corporation, where she continues to innovate in the field of biotechnology. Her work has been instrumental in advancing the methodologies used in immune repertoire analysis, which is crucial for understanding various immune responses.
Collaborations
She has collaborated with notable colleagues such as Geoffrey Lowman and Timothy Looney, contributing to the development of her innovative patents.
Conclusion
Elizabeth Linch's contributions to immune repertoire sequencing represent a significant advancement in biotechnology. Her patents not only enhance the understanding of immune responses but also pave the way for future innovations in the field.
